OUR SPECIALTY
Oncology Portfolio
Medinox JBN Ltd focuses on the importation and supply of oncology (cancer) medicines, spanning the following therapeutic classes — including but not limited to:
Cytotoxic Chemotherapy
Paclitaxel · Docetaxel · Carboplatin · Doxorubicin · Cyclophosphamide
Targeted Therapy
Imatinib · Erlotinib · Sorafenib · Sunitinib · Bortezomib
Monoclonal Antibodies
Bevacizumab · Rituximab · Trastuzumab
Hormonal / Endocrine Therapy
Tamoxifen · Anastrozole · Letrozole · Abiraterone · Bicalutamide
Immunomodulators & Haematology
Lenalidomide · Pomalidomide · Hydroxyurea · Deferasirox
Supportive & Adjunct Care
Ondansetron · Dexamethasone · Filgrastim · Zoledronic acid
Please note · Please note: availability of specific products depends on registration and approval by the Tanzania Medicines and Medical Devices Authority (TMDA), market demand and manufacturer supply schedules. Names shown are generic active ingredients, listed for reference only.
STRATEGIC ALLIANCE
Our Manufacturing Partner
Medinox JBN Ltd works in partnership with Apotex Inc. of Canada — one of the world's leading producers of high-quality, affordable generic and specialty medicines.
Through this relationship, Medinox is able to bring internationally manufactured, quality-assured pharmaceutical products to the Tanzanian market, strengthening access to safe, effective and affordable treatment for healthcare providers and patients across the country.
WHAT THIS MEANS FOR OUR CUSTOMERS
- Quality-assured sourcing from a globally recognised manufacturer.
- Products manufactured to recognised international quality standards.
- A broader portfolio of human medicines for the Tanzanian market.
- Reliable, continuous supply through an established partner.
Note · Please note: all products introduced through this partnership are supplied subject to registration and approval by the Tanzania Medicines and Medical Devices Authority (TMDA). Product and brand names referenced remain the property of their respective owners.
TRUST & STANDARDS
Quality & Compliance
Quality and patient safety sit at the centre of everything we do — from sourcing through to final delivery.
Regulatory Compliance
Products are imported and distributed within the regulatory framework of the TMDA.
Supplier Qualification
We source only from reputable manufacturers meeting recognised quality standards.
Good Distribution Practice
Distribution processes are designed to safeguard medicine quality and safety.
Storage & Handling
Appropriate storage conditions and careful handling preserve product integrity.
Traceability
Proper documentation supports traceability throughout the supply chain.
Patient Focus
Every control exists for one reason — the safety of the patients we ultimately serve.